Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic Adenocarcinoma

Clinical trial NCT05525286 · TERMINATED

Trial details

NCT number: NCT05525286
Sponsor: SOTIO Biotech a.s.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2022-03-31
Primary completion: 2024-12-13
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.